720 A phase 1/2 study of BDC-3042, a novel Dectin-2 agonistic antibody, in patients with advanced cancers
Main Authors: | Edith A Perez, Lu Xu, Antonio Giordano, Justin Kenkel, Shelley E Ackerman, Michael N Alonso, Sharon Wilks, Aparna R Parikh, Danlin Cai, Damon Demady |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
Similar Items
-
Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients
by: Roberto Teggi, et al.
Published: (2021-10-01) -
Synthesis, characterization and CO2 adsorption studies of DABCO based pillared Zn-BDC and Co-BDC metal organic frameworks
by: Ijlal Aamer, et al.
Published: (2021-01-01) -
Dectin-1
by: Herre, J, et al.
Published: (2004) -
Dectin-mediated Ca2+ flux in dendritic cells.
by: Ismawati Mohamad Amin.
Published: (2010) -
The Effects of the S1P Receptor Agonist Fingolimod (FTY720) on Central and Peripheral Myelin in Twitcher Mice
by: Sibylle Béchet, et al.
Published: (2024-03-01)